Theseus Pharmaceuticals, Inc. logo

Theseus Pharmaceuticals, Inc. Share Price (NASDAQ: THRX)

▲

-4.06

(-100%)

Live

Last updated on

Bell Icon

The stock has been delisted from the stock exchange on 13 Feb 2024

Check the interactive Theseus Pharmaceuticals, Inc. Stock chart to analyse performance

Theseus Pharmaceuticals, Inc. Key Stats

Check Theseus Pharmaceuticals, Inc. key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$4.06
Open
$4.06
Market Capitalization
$181.7M
Today's Volume
$3.1M
Revenue TTM
$0.0
EBITDA
$-66.4M
Earnings Per Share (EPS)
$-1.34
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-25.55%

Global Institutional Holdings in Theseus Pharmaceuticals, Inc.

  • Name

    Holdings %

  • Orbimed Advisors, LLC

    40.05%

  • Foresite Capital Management V, LLC

    9.29%

  • Millennium Management LLC

    3.88%

  • BlackRock Inc

    3.03%

  • T. Rowe Price Associates, Inc.

    2.75%

  • Vanguard Group Inc

    1.78%

Analyst Recommendation on Theseus Pharmaceuticals, Inc. Stock

Rating
Trend

Buy

    75%Buy

    25%Hold

    0%Sell

Based on 12 Wall street analysts offering stock ratings for Theseus Pharmaceuticals, Inc.(by analysts ranked 0 to 5 stars)

About Theseus Pharmaceuticals, Inc.

Theseus Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of targeted therapies for the treatment of cancer patients. Its lead product candidate is THE-630, a pan-KIT inhibitor for the treatment of gastrointestinal stromal tumors. The company also develops THE-349, a fourth-generation selective epidermal growth factor receptor inhibitor to address C797X-mediated resistance to first- or later-line osimertinib treatment in patients with non-small cell lung cancer. Its development programs address drug resistance mutations in key driver oncogenes, which are mutated genes that cause cancer. The company was incorporated in 2017 and is based in Cambridge, Massachusetts.
Organization
Theseus Pharmaceuticals, Inc.
Employees
38
CEO
Dr. Iain D. Dukes DPHIL, M.A.
Industry
Miscellaneous

Important FAQs about investing in THRX Stock from India :

What is Theseus Pharmaceuticals, Inc. share price today?

Theseus Pharmaceuticals, Inc. share price today is as on . Theseus Pharmaceuticals, Inc. share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Theseus Pharmaceuticals, Inc. share?

Theseus Pharmaceuticals, Inc. share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Theseus Pharmaceuticals, Inc. stock price today i.e. is trending at , lower by 100% versus the 52 week high.

How to invest in Theseus Pharmaceuticals, Inc. Stock (THRX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Theseus Pharmaceuticals, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Theseus Pharmaceuticals, Inc. Shares .

What is the minimum amount required to buy Theseus Pharmaceuticals, Inc. Stock (THRX) from India?

Indian investors can start investing in Theseus Pharmaceuticals, Inc. (THRX) shares with as little as ₹89.9525 or $1 (as of January 08, 2026) using the INDmoney app.
For example: If you want to invest $10 or ₹899.52 in Theseus Pharmaceuticals, Inc. stock (as per the Rupee-Dollar exchange rate as on January 08, 2026). Learn more about fractional shares .

What are the returns that Theseus Pharmaceuticals, Inc. has given to Indian investors in the last 5 years?

Theseus Pharmaceuticals, Inc. stock has given 0.0% share price returns and 22.99% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?